in clinical trials is underscored by a track record of repeat business, industry excellence awards, and consistent performance in bringing therapies to market. "For the past two decades, Emerald Clinical Trials has been focused on delivering high...
often come with risks like drug interactions or steroid-related side effects. PBZ OTC changes that with a steroid-free formula gentle enough for children as young as two, yet strong enough for adults. Its unique ability to pair safely with oral...
Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform to support genetic target identification and validation, and generation of disease-relevant cellular models. The platform...
stem cells. Product Overview Product name: KGF alternative peptide (FGFR2b agonist) Product code: PG-012 Product form: Lyophilized Storage conditions: -20°C or less Purity: ≥95% by HPLC Molecular weight: 6018.40 (Acetate) Size: 10 μg, 100 μg, 1 mg...
areas of high unmet medical needs such as obesity/metabolism, oncology, and rare diseases. Hanmi leverages proprietary platform technologies, including long-acting biologics and bispecific antibodies, to address unmet medical needs. The company...
knowledge, technology-driven approach, and operational scalability will expand ELIQUENT’s pharmacovigilance platform to offer clients a premier partner for regulatory success,” said Tim Dietlin, Chief Executive Officer, ELIQUENT Life Sciences....
Bruin Biometrics LLC, a medical technology platform company that provides digital solutions for pressure injury prevention and management to health systems in the U.S. and U.K., announced it has been named by Fast Company as one of the World's 10...
foot and ankle orthopedic devices market insights, nearly 300,000 foot and ankle sports medicine procedures are performed in the U.S. each year, with ankle instability procedures representing approximately 44% of these surgical procedures. The...
According to Fernanda Bertasi, General Manager of Pint Pharma in Brazil, "ANVISA’s approval of BESREMi® represents a transformative milestone for patients with Polycythemia Vera in Brazil. This new therapeutic option brings real hope, offering...
this strategic evolution underscores the Company’s true identity as the pioneer of NAD+ research and innovator behind transformative NAD-boosting healthy-aging solutions. At the forefront is Niagen Bioscience’s clinically proven, patented flagship...
dental clinics. About Medit: MEDIT is a global provider of 3D intraoral scanners and an all-in-one digital dentistry platform, based on its own patented state-of-the-art technology. The company also develops innovative software for digital...
patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron. For more information, please visit: https://www.actiniumpharma.com/
for the arts and sciences. The foundation was established in 2000 by Jan and Marica Vilcek, immigrants from the former Czechoslovakia. The foundation's mission was inspired by the couple's respective careers in biomedical science and art history....
Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers and novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need. Our continually evolving portfolio...
addition to advancing drug candidate safety and dosing, positive trial results will bolster confidence in the BioPYM platform as a groundbreaking therapeutics modality. No needle oral biologics with no cold-chain will transform the patient...
settings. The latest analysis builds upon prior research, including the LIGHT trial, and complements the ongoing INFORMUS trial, a large-scale cardiovascular outcomes study, which now has enrolled more than 3,000 patients and is designed to meet...
Agonist, across the full supply chain from drug substance to drug product for both its subcutaneous and oral peptide formulations. CordenPharma is committed to ensuring seamless development and commercialization of Viking Therapeutics' VK2735 drug...
designed to enhance mucosal immunity in individuals with compromised immune systems. The grant will advance Lactiga's platform sIgA technology while expanding Kenox's capabilities in inhaled and intranasal biologic delivery systems. "We are...
Head of Patient Evidence, UCB. "These five-year results highlight the robust potential of bimekizumab-bkzx in transforming patient outcomes by offering the possibility of lasting, complete skin clearance. Bimekizumab-bkzx is aiming to set a new...
MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva...
